[B031] 医药新闻

{
  "data": {
    "drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "tags": [
      "Careers",
      "Resume",
      "BioSpace",
      "advice"
    ],
    "title": "Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)",
    "author": [
      "Thomas  Fink"
    ],
    "target": [
      {
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "channel": [
      "company information"
    ],
    "content": "The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeks\\nSusvimo offers the first alternative to regular eye injections that are standard of care for nAMD, which impacts 20 million people worldwide and can cause blindness if left untreated",
    "disease": [
      {
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "news_id": "f57e970e-8f97-39b7-a6be-51846e92bee1",
    "post_time": 1720600697798,
    "source_url": "https://www.biospace.com/article/releases/cerevel-therapeutics-announces-publication-in-the-lancet-of-emraclidine-data-from-phase-1b-clinical-trial-in-people-living-with-schizophrenia/",
    "organization": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ]
  },
  "status": true,
  "error_code": 0
}